2026-06-03T15:41:39+08:00 weekly 1.0 https://yua.neopharmhk.com/ 2026-06-05T03:47:58+08:00 weekly 0.9 https://yua.neopharmhk.com/our-services 2026-06-05T03:46:03+08:00 weekly 0.9 https://yua.neopharmhk.com/about-us 2026-06-05T03:45:50+08:00 weekly 0.9 https://yua.neopharmhk.com/contact-us 2026-06-05T03:45:53+08:00 weekly 0.9 https://yua.neopharmhk.com/inquiry 2026-08-14T18:28:01+08:00 weekly 0.9 https://yua.neopharmhk.com/newslist-1 2026-06-05T03:46:07+08:00 weekly 0.9 https://yua.neopharmhk.com/info/ 2026-08-14T18:28:01+08:00 weekly 0.9 https://yua.neopharmhk.com/products 2026-05-19T16:19:22+08:00 weekly 0.9 https://yua.neopharmhk.com/finished-dosage-form/ 2026-05-19T16:19:25+08:00 weekly 0.9 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/ 2026-06-05T03:38:46+08:00 weekly 0.9 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/anti-infective-agents/ 2026-06-05T03:38:54+08:00 weekly 0.9 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/cardiovascular-agents/ 2026-06-05T03:38:57+08:00 weekly 0.9 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/nervous-system-agents/ 2026-06-05T03:38:58+08:00 weekly 0.9 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/antineoplastic-agents/ 2026-06-05T03:39:00+08:00 weekly 0.9 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/endocrine-metabolic-agents/ 2026-06-05T03:39:06+08:00 weekly 0.9 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/nutrients-adjuncts/ 2026-06-05T03:39:08+08:00 weekly 0.9 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/ophthalmic-agents/ 2026-06-05T03:39:13+08:00 weekly 0.9 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/digestive-system-agents/ 2026-06-05T03:39:16+08:00 weekly 0.9 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/peptide-agents/ 2026-06-05T03:39:25+08:00 weekly 0.9 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/diagnostic-imaging-agents/ 2026-06-09T18:51:30+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/nervous-system-agents/atogepant-cas-1374248-81-3.html 2026-06-09T18:53:22+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/nervous-system-agents/eplontersen-api.html 2026-06-09T18:51:30+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/nervous-system-agents/zavegepant-hydrochloride.html 2026-06-09T18:51:51+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/antineoplastic-agents/risdiplam.html 2026-06-09T18:53:25+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/endocrine-metabolic-agents/finerenone-api.html 2026-06-09T18:51:26+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/antineoplastic-agents/dexrazoxane-raw-material.html 2026-06-09T18:51:20+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/antineoplastic-agents/donidalorsen.html 2026-06-09T18:53:28+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/endocrine-metabolic-agents/estradiol-api.html 2026-06-09T18:51:55+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/antineoplastic-agents/nusinersen.html 2026-06-09T18:51:49+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/nervous-system-agents/ubrogepant-raw-material.html 2026-06-09T18:51:53+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/antineoplastic-agents/abiraterone-acetate-api.html 2026-06-09T18:51:47+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/ophthalmic-agents/diquafosol-sodium.html 2026-06-09T18:51:50+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/diagnostic-imaging-agents/gadobutrol-fda.html 2026-06-09T18:53:36+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/endocrine-metabolic-agents/cagrilintide-and-semaglutide.html 2026-06-09T18:53:50+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/peptide-agents/ganirelix-api.html 2026-06-09T18:51:49+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/endocrine-metabolic-agents/carbetocin-api.html 2026-06-09T18:53:32+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/peptide-agents/linaclotide-api.html 2026-06-09T18:51:50+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/nutrients-adjuncts/edaravone-fda.html 2026-06-09T18:56:23+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/peptide-agents/glatiramer-api.html 2026-06-09T18:53:47+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/endocrine-metabolic-agents/terlipressin-fda.html 2026-06-09T18:54:08+08:00 weekly 0.8 https://yua.neopharmhk.com/finished-dosage-form/glatiramer-acetate.html 2026-06-09T18:52:55+08:00 weekly 0.8 https://yua.neopharmhk.com/finished-dosage-form/vortioxetine-hydrobromide-tablets.html 2026-06-09T18:53:46+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/antineoplastic-agents/degarelix-api.html 2026-06-09T18:52:57+08:00 weekly 0.8 https://yua.neopharmhk.com/finished-dosage-form/diquafosol-sodium-eye-drops.html 2026-06-09T18:53:54+08:00 weekly 0.8 https://yua.neopharmhk.com/finished-dosage-form/carbetocin-vial.html 2026-06-09T18:54:41+08:00 weekly 0.8 https://yua.neopharmhk.com/finished-dosage-form/semaglutide-injection.html 2026-06-09T18:54:28+08:00 weekly 0.8 https://yua.neopharmhk.com/finished-dosage-form/bonista-of-injection.html 2026-06-09T18:53:05+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/nutrients-adjuncts/purchase-vitamin-k2.html 2026-06-09T18:53:42+08:00 weekly 0.8 https://yua.neopharmhk.com/finished-dosage-form/atosiban-acetate-injection.html 2026-06-09T18:55:31+08:00 weekly 0.8 https://yua.neopharmhk.com/finished-dosage-form/azunate-60-mg-injection.html 2026-06-09T18:52:56+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/nutrients-adjuncts/coenzyme-a-assay.html 2026-06-09T18:53:38+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/endocrine-metabolic-agents/liraglutide-api.html 2026-06-09T18:53:36+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/antineoplastic-agents/octreotide-api.html 2026-06-09T18:54:08+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/endocrine-metabolic-agents/oxytocin.html 2026-06-09T18:53:31+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/antineoplastic-agents/lanreotide-api.html 2026-06-09T18:54:59+08:00 weekly 0.8 https://yua.neopharmhk.com/finished-dosage-form/lanreotide-injection.html 2026-06-09T18:53:20+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/peptide-agents/etelcalcetide-powder.html 2026-06-09T18:53:34+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/peptide-agents/abaloparatide-fda.html 2026-06-09T18:54:03+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/endocrine-metabolic-agents/atosiban-api.html 2026-06-09T18:53:37+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/peptide-agents/plecanatide-powder.html 2026-06-09T18:53:01+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/nervous-system-agents/levodopa-powder.html 2026-06-09T18:55:10+08:00 weekly 0.8 https://yua.neopharmhk.com/finished-dosage-form/terlipressin-1-mg.html 2026-06-09T18:54:19+08:00 weekly 0.8 https://yua.neopharmhk.com/finished-dosage-form/etelcalcetide-hydrochloride.html 2026-06-09T18:52:25+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/antineoplastic-agents/milrinone-powder.html 2026-06-09T18:52:24+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/diagnostic-imaging-agents/gadolinium-fda.html 2026-06-09T18:52:47+08:00 weekly 0.8 https://yua.neopharmhk.com/finished-dosage-form/propofol-medium-and-long-chain-fat-emulsion.html 2026-06-09T18:54:22+08:00 weekly 0.8 https://yua.neopharmhk.com/finished-dosage-form/linaclotide-capsules.html 2026-06-09T18:54:57+08:00 weekly 0.8 https://yua.neopharmhk.com/finished-dosage-form/liraglutide-injection.html 2026-06-09T18:52:48+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/nervous-system-agents/citicoline-sodium-api.html 2026-06-09T18:53:39+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/endocrine-metabolic-agents/semaglutide-raw-material.html 2026-06-09T18:52:24+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/antineoplastic-agents/lenalidomide-api.html 2026-06-09T18:53:02+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/endocrine-metabolic-agents/tamoxifen-citrate-powder.html 2026-06-09T18:52:36+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/antineoplastic-agents/propofol-api.html 2026-06-09T18:52:36+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/anti-infective-agents/sitafloxacin-fda-approval.html 2026-06-09T18:52:26+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/antineoplastic-agents/afatinib-dimaleate.html 2026-06-09T18:52:49+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/digestive-system-agents/ademetionine-butanedisulfonate.html 2026-06-09T18:52:36+08:00 weekly 0.8 https://yua.neopharmhk.com/finished-dosage-form/dexmedetomidine-hydrochloride-injection.html 2026-06-09T18:52:35+08:00 weekly 0.8 https://yua.neopharmhk.com/finished-dosage-form/sitafloxacin-tablets.html 2026-06-09T18:51:19+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/cardiovascular-agents/inclisiran-sodium-api.html 2026-06-09T18:55:35+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/cardiovascular-agents/resmetirom-api.html 2026-06-09T18:56:04+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/cardiovascular-agents/eplerenone-api.html 2026-06-09T18:57:22+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/nervous-system-agents/suzetrigine-api.html 2026-06-09T18:55:17+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/endocrine-metabolic-agents/dydrogesterone-api.html 2026-06-09T18:55:47+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/nervous-system-agents/loxoprofen-sodium-dihydrate.html 2026-06-09T18:51:31+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/nervous-system-agents/dexmedetomidine-hydrochloride.html 2026-06-09T18:51:51+08:00 weekly 0.8 https://yua.neopharmhk.com/active-pharmaceutical-ingredient/endocrine-metabolic-agents/epalrestat-fda.html 2026-08-26T11:16:34+08:00 weekly 0.8 https://yua.neopharmhk.com/news/csl-slashes-revenue-projection-17879707828315136.html 2026-08-26T11:16:29+08:00 weekly 0.8 https://yua.neopharmhk.com/news/eu-recommendations-for-2026-2027-seasonal-flu-17879707899225088.html 2026-08-26T11:16:26+08:00 weekly 0.8 https://yua.neopharmhk.com/news/cphi-china-2026-the-definitive-hub-for-global-17879707956782080.html 2026-08-26T11:16:41+08:00 weekly 0.8 https://yua.neopharmhk.com/info/citicoline-sodium-introduction-18002984915493888.html 2026-08-26T11:15:14+08:00 weekly 0.8 https://yua.neopharmhk.com/info/dexmedetomidine-hydrochloride-injection-dosage-17879708004131840.html 2026-08-26T11:15:06+08:00 weekly 0.8 https://yua.neopharmhk.com/info/in-what-situations-are-prophylactic-antibiotic-17879707947934720.html 2026-08-26T11:15:18+08:00 weekly 0.8 https://yua.neopharmhk.com/info/is-sitafloxacin-a-cephalosporin-17879707940758528.html 2026-08-26T11:15:16+08:00 weekly 0.8 https://yua.neopharmhk.com/info/how-to-take-vortioxetine-hydrobromide-tablets-17879707940217856.html 2026-08-26T11:15:51+08:00 weekly 0.8 https://yua.neopharmhk.com/info/application-scenarios-of-intermediates-17879707935368192.html 2026-08-26T11:16:33+08:00 weekly 0.8 https://yua.neopharmhk.com/info/application-areas-and-development-trends-of-dr-17879707934434304.html 2026-08-26T11:16:22+08:00 weekly 0.8 https://yua.neopharmhk.com/info/the-core-functions-of-drug-formulation-17879707932386304.html 2026-08-26T11:15:06+08:00 weekly 0.8 https://yua.neopharmhk.com/info/principles-of-antimicrobial-drug-use-17879707931468800.html 2026-08-26T11:16:10+08:00 weekly 0.8 https://yua.neopharmhk.com/info/importance-of-formulation-17879707928421376.html 2026-08-26T11:15:23+08:00 weekly 0.8 https://yua.neopharmhk.com/info/what-are-the-detailed-instructions-for-using-d-17879707927979008.html 2026-08-26T11:14:56+08:00 weekly 0.8 https://yua.neopharmhk.com/info/composition-and-structure-of-antibacterial-age-17879707919180800.html 2026-08-26T11:24:34+08:00 weekly 0.8 https://yua.neopharmhk.com/info/pharmaceutical-formulation-development-trends-17879707909776384.html 2026-08-26T11:15:04+08:00 weekly 0.8 https://yua.neopharmhk.com/info/how-to-properly-store-antibiotics-17879707909088256.html 2026-08-26T11:16:09+08:00 weekly 0.8 https://yua.neopharmhk.com/info/what-is-an-intermediate-17879707906008064.html 2026-08-26T11:15:58+08:00 weekly 0.8 https://yua.neopharmhk.com/info/current-status-and-development-trends-of-the-i-17879707895833600.html 2026-08-26T11:15:15+08:00 weekly 0.8 https://yua.neopharmhk.com/info/what-diseases-does-vortioxetine-hydrobromide-t-17879707891344384.html 2026-08-26T11:15:52+08:00 weekly 0.8 https://yua.neopharmhk.com/info/technical-principles-of-intermediates-17879707890492416.html 2026-08-26T11:15:54+08:00 weekly 0.8 https://yua.neopharmhk.com/info/definition-and-importance-of-intermediates-17879707888706560.html 2026-08-26T11:15:49+08:00 weekly 0.8 https://yua.neopharmhk.com/info/what-are-intermediates-17879707884839936.html 2026-08-26T11:15:45+08:00 weekly 0.8 https://yua.neopharmhk.com/info/history-of-antioxidant-development-17879707883545600.html